Use of the wearable cardioverter-defibrillator – the Swiss experience
Boldizsar Kovacs(University of Michigan), Fırat Duru(University of Malta), Laurent Roten(University of Bern), Urs Eriksson(GZO Spital Wetzikon), Jan Berg(Kantonsspital Aarau), Richard Kobza(Leipzig Heart Institute), Roman Brenner(Kantonsspital St. Gallen), Jan Steffel(Zurich Heart House), Ardan M. Saguner(University of Zurich), Giulia Domenichini(University of Lausanne), Jürg Schläpfer, Haran Burri, Beat Schaer(University of Basel), Nazmi Krasniqi(GZO Spital Wetzikon), A. Linka(Kantonsspital Winterthur), Laurent Haegeli(Zurich Heart House), Christian Sticherling(University Hospital of Basel), Christian Grebmer(Luzerner Kantonsspital), Tobias Reichlin(University Hospital of Bern), Andreas S. Müller(Triemli Hospital), Kurt Mayer(Kantonsspital Graubünden), Omer Dzemali(Triemli Hospital), Sven Reek(Hirslanden Klinik Aarau), Peter Ammann(University of St.Gallen)
Cited by 14
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
|European Heart Journal|2018|2.1k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k